RhumbLine Advisers’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $979K | Sell |
|
|||||
|
2025
Q2 | $1.33M | Buy |
|
|||||
|
2025
Q1 | $542K | Buy |
|
|||||
|
2024
Q4 | $504K | Buy |
|
|||||
|
2024
Q3 | $321K | Sell |
|
|||||
|
2024
Q2 | $252K | Buy |
|
|||||
|
2024
Q1 | $9.01K | Hold |
|
|||||
|
2023
Q4 | $6.11K | Hold |
|
|||||
|
2023
Q3 | $5.62K | Hold |
|
|||||
|
2023
Q2 | $4.51K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $147K | Sell |
|
|||||
|
2021
Q4 | $477K | Buy |
|
|||||
|
2021
Q3 | $606K | Buy |
|
|||||
|
2021
Q2 | $769K | Buy |
|
|||||
|
2021
Q1 | $590K | Sell |
|
|||||
|
2020
Q4 | $529K | Buy |
|
|||||
|
2020
Q3 | $442K | Sell |
|
|||||
|
2020
Q2 | $2.84M | Sell |
|
|||||
|
2020
Q1 | $1.63M | Buy |
|
|||||
|
2019
Q4 | $1.16M | Buy |
|
|||||
|
2019
Q3 | $695K | Buy |
|
|||||
|
2019
Q2 | $780K | Buy |
|
|||||
|
2019
Q1 | $920K | Sell |
|
|||||
|
2018
Q4 | $671K | Buy |
|
|||||
|
2018
Q3 | $399K | Sell |
|
|||||
|
2018
Q2 | $476K | Buy |
|
|||||
|
2018
Q1 | $391K | Buy |
|
|||||
|
2017
Q4 | $606K | Sell |
|
|||||
|
2017
Q3 | $881K | Buy |
|
|||||
|
2017
Q2 | $596K | Buy |
|
|||||
|
2017
Q1 | $377K | Buy |
|
|||||
|
2016
Q4 | $414K | Sell |
|
|||||
|
2016
Q3 | $421K | Buy |
|
|||||
|
2016
Q2 | $343K | Buy |
|
|||||
|
2016
Q1 | $405K | Buy |
|
|||||
|
2015
Q4 | $424K | Buy |
|
|||||
|
2015
Q3 | $307K | Buy |
|
|||||
|
2015
Q2 | $308K | Buy |
|